230 related articles for article (PubMed ID: 8808751)
1. Abnormal cholesterol biosynthesis in the Smith-Lemli-Opitz syndrome.
Salen G; Shefer S; Batta AK; Tint GS; Xu G; Honda A; Irons M; Elias ER
J Lipid Res; 1996 Jun; 37(6):1169-80. PubMed ID: 8808751
[TBL] [Abstract][Full Text] [Related]
2. Abnormal cholesterol biosynthesis in the Smith-Lemli-Opitz syndrome.
Salen G; Tint GS; Xu G; Batta AK; Irons M; Elias ER
Ital J Gastroenterol; 1995 Dec; 27(9):506-8. PubMed ID: 8919321
[TBL] [Abstract][Full Text] [Related]
3. 7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome.
Fitzky BU; Moebius FF; Asaoka H; Waage-Baudet H; Xu L; Xu G; Maeda N; Kluckman K; Hiller S; Yu H; Batta AK; Shefer S; Chen T; Salen G; Sulik K; Simoni RD; Ness GC; Glossmann H; Patel SB; Tint GS
J Clin Invest; 2001 Sep; 108(6):905-15. PubMed ID: 11560960
[TBL] [Abstract][Full Text] [Related]
4. Defective conversion of 7-dehydrocholesterol to cholesterol in cultured skin fibroblasts from Smith-Lemli-Opitz syndrome homozygotes.
Honda A; Tint GS; Salen G; Batta AK; Chen TS; Shefer S
J Lipid Res; 1995 Jul; 36(7):1595-601. PubMed ID: 7595082
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and genetic aspects of 7-dehydrocholesterol reductase and Smith-Lemli-Opitz syndrome.
Waterham HR; Wanders RJ
Biochim Biophys Acta; 2000 Dec; 1529(1-3):340-56. PubMed ID: 11111101
[TBL] [Abstract][Full Text] [Related]
6. Abnormal cholesterol biosynthesis in sitosterolaemia and the Smith-Lemli-Opitz syndrome.
Salen G; Shefer S; Batta AK; Tint GS; Xu G; Honda A
J Inherit Metab Dis; 1996; 19(4):391-400. PubMed ID: 8884563
[TBL] [Abstract][Full Text] [Related]
7. [Inborn error of cholesterol biosynthesis: Smith-Lemli-Opitz syndrome].
Koczok K; V Oláh A; P Szabó G; Oláh É; Török O; Balogh I
Orv Hetil; 2015 Oct; 156(42):1695-702. PubMed ID: 26551309
[TBL] [Abstract][Full Text] [Related]
8. Smith-Lemli-Opitz syndrome is caused by mutations in the 7-dehydrocholesterol reductase gene.
Waterham HR; Wijburg FA; Hennekam RC; Vreken P; Poll-The BT; Dorland L; Duran M; Jira PE; Smeitink JA; Wevers RA; Wanders RJ
Am J Hum Genet; 1998 Aug; 63(2):329-38. PubMed ID: 9683613
[TBL] [Abstract][Full Text] [Related]
9. Mutational spectrum in the Delta7-sterol reductase gene and genotype-phenotype correlation in 84 patients with Smith-Lemli-Opitz syndrome.
Witsch-Baumgartner M; Fitzky BU; Ogorelkova M; Kraft HG; Moebius FF; Glossmann H; Seedorf U; Gillessen-Kaesbach G; Hoffmann GF; Clayton P; Kelley RI; Utermann G
Am J Hum Genet; 2000 Feb; 66(2):402-12. PubMed ID: 10677299
[TBL] [Abstract][Full Text] [Related]
10. Changes in serum sterols of rats treated with 7-dehydrocholesterol-delta 7-reductase inhibitors: comparison to levels in humans with Smith-Lemli-Opitz syndrome.
Wolf C; Chevy F; Pham J; Kolf-Clauw M; Citadelle D; Mulliez N; Roux C
J Lipid Res; 1996 Jun; 37(6):1325-33. PubMed ID: 8808767
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the human sterol delta7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome.
Wassif CA; Maslen C; Kachilele-Linjewile S; Lin D; Linck LM; Connor WE; Steiner RD; Porter FD
Am J Hum Genet; 1998 Jul; 63(1):55-62. PubMed ID: 9634533
[TBL] [Abstract][Full Text] [Related]
12. Markedly inhibited 7-dehydrocholesterol-delta 7-reductase activity in liver microsomes from Smith-Lemli-Opitz homozygotes.
Shefer S; Salen G; Batta AK; Honda A; Tint GS; Irons M; Elias ER; Chen TC; Holick MF
J Clin Invest; 1995 Oct; 96(4):1779-85. PubMed ID: 7560069
[TBL] [Abstract][Full Text] [Related]
13. The Smith-Lemli-Opitz syndrome: a potentially fatal birth defect caused by a block in the last enzymatic step in cholesterol biosynthesis.
Tint GS; Batta AK; Xu G; Shefer S; Honda A; Irons M; Elias ER; Salen G
Subcell Biochem; 1997; 28():117-44. PubMed ID: 9090293
[No Abstract] [Full Text] [Related]
14. Discordant phenotype and sterol biochemistry in Smith-Lemli-Opitz syndrome.
Koo G; Conley SK; Wassif CA; Porter FD
Am J Med Genet A; 2010 Aug; 152A(8):2094-8. PubMed ID: 20635399
[TBL] [Abstract][Full Text] [Related]
15. Regulation of cholesterol biosynthetic pathway in patients with the Smith-Lemli-Opitz syndrome.
Honda M; Tint GS; Honda A; Salen G; Shefer S; Batta AK; Matsuzaki Y; Tanaka N
J Inherit Metab Dis; 2000 Jul; 23(5):464-74. PubMed ID: 10947201
[TBL] [Abstract][Full Text] [Related]
16. Smith-Lemli-Opitz syndrome and the DHCR7 gene.
Jira PE; Waterham HR; Wanders RJ; Smeitink JA; Sengers RC; Wevers RA
Ann Hum Genet; 2003 May; 67(Pt 3):269-80. PubMed ID: 12914579
[TBL] [Abstract][Full Text] [Related]
17. Identification of 19-nor-5,7,9(10)-cholestatrien-3 beta-ol in patients with Smith-Lemli-Opitz syndrome.
Batta AK; Salen G; Tint GS; Shefer S
J Lipid Res; 1995 Nov; 36(11):2413-8. PubMed ID: 8656079
[TBL] [Abstract][Full Text] [Related]
18. Reproducing abnormal cholesterol biosynthesis as seen in the Smith-Lemli-Opitz syndrome by inhibiting the conversion of 7-dehydrocholesterol to cholesterol in rats.
Xu G; Salen G; Shefer S; Ness GC; Chen TS; Zhao Z; Tint GS
J Clin Invest; 1995 Jan; 95(1):76-81. PubMed ID: 7814648
[TBL] [Abstract][Full Text] [Related]
19. Smith-Lemli-Opitz syndrome: phenotypic extreme with minimal clinical findings.
Nowaczyk MJ; Whelan DT; Hill RE
Am J Med Genet; 1998 Aug; 78(5):419-23. PubMed ID: 9714007
[TBL] [Abstract][Full Text] [Related]
20. Rapid identification of Smith-Lemli-Opitz syndrome homozygotes and heterozygotes (carriers) by measurement of deficient 7-dehydrocholesterol-delta 7-reductase activity in fibroblasts.
Shefer S; Salen G; Honda A; Batta A; Hauser S; Tint GS; Honda M; Chen T; Holick MF; Nguyen LB
Metabolism; 1997 Jul; 46(7):844-50. PubMed ID: 9225842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
